Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits

Glucagon-like peptide-1 (GLP-1) is thought to inhibit development of aortic atherosclerosis and plaque formation. However, whether GLP-1 stabilizes fully developed atherosclerotic plaque or alters the complicated plaque composition remains unclarified. Ten Watanabe heritable hyperlipidemic (WHHL) ra...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Atherosclerosis Ročník 265; s. 283 - 291
Hlavní autori:	Sudo, Mitsumasa, Li, Yuxin, Hiro, Takafumi, Takayama, Tadateru, Mitsumata, Masako, Shiomi, Masashi, Sugitani, Masahiko, Matsumoto, Taro, Hao, Hiroyuki, Hirayama, Atsushi
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Ireland Elsevier B.V 01.10.2017
Predmet:	Animals Atherosclerosis Diabetes mellitus Disease Progression Glucagon-Like Peptide-1 Receptor - agonists Hyperlipidemias - complications Hyperlipidemias - genetics Imaging Male Plaque Plaque, Atherosclerotic - diagnostic imaging Plaque, Atherosclerotic - etiology Plaque, Atherosclerotic - pathology Plaque, Atherosclerotic - prevention & control Rabbits Ultrasonics Ultrasonography, Interventional Imaging Diabetes mellitus Atherosclerosis Plaque Ultrasonics
ISSN:	0021-9150, 1879-1484, 1879-1484
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!